[February 27, 2015]

Research and Markets: Diabetic Macular Edema Therapeutics Pipeline Review 2015 - Analysis of 31 Companies & 39 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/w7sh9d/diabetic_macular) has announced the addition of the "Diabetic Macular Edema - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Diabetic Macular Edema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Macular Edema and special features on late-stage and discontinued project.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• ActiveSite Pharmaceuticals, Inc.
• Acucela Inc.
• Aerpio Therapeutics, Inc.
• Alcon, Inc.
• Allergan, Inc.
• AlphaMab Co., Ltd
• Ampio Pharmaceuticals, Inc.
• Astellas Pharma Inc.
• Auven Therapeutics Management L.L.L.P
• Avalanche Biotechnologies, Inc.
• Eleven Biotherapeutics Inc.
• F. Hoffmann-La Roche Ltd.
• Foamix Pharmaceuticals Ltd.
• Gene Signal International SA
• Genmab A/S
• GlaxoSmithKline plc
• Icon Bioscience, Inc.
• Kala Pharmaceuticals, Inc.
• Kowa Company, Ltd.
• Mabion SA
• MacuCLEAR, Inc.
• Molecular Design International, Inc.
• NicOx S.A.
• Ohr Pharmaceutical Inc.
• Pfizer Inc.
• Quark Pharmaceuticals, Inc.
• Regeneron Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
• SciFluor Life Sciences, LLC
• Senju Pharmaceutical Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/w7sh9d/diabetic_macular

[ Back To TMCnet.com's Homepage ]